Cargando…
A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions
Bisphosphonates (BPs) are the first-line treatment of bone loss resulting from various pathological conditions. Due to their high affinity to bone they have been used to develop conjugates with pro-anabolic or anti-catabolic drugs. We recently demontrated that hydrogen sulfide (H(2)S), promotes oste...
Autores principales: | Rapposelli, Simona, Gambari, Laura, Digiacomo, Maria, Citi, Valentina, Lisignoli, Gina, Manferdini, Cristina, Calderone, Vincenzo, Grassi, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607332/ https://www.ncbi.nlm.nih.gov/pubmed/28931828 http://dx.doi.org/10.1038/s41598-017-11608-z |
Ejemplares similares
-
Cartilage and Bone Serum Biomarkers as Novel Tools for Monitoring Knee Osteochondritis Dissecans Treated with Osteochondral Scaffold
por: Gabusi, Elena, et al.
Publicado: (2018) -
Memantine prodrug as a new agent for Alzheimer’s Disease
por: Sestito, Simona, et al.
Publicado: (2019) -
The Use of Anabolic Agents in Catabolic States
por: Demling, Robert
Publicado: (2007) -
Clinical and Biological Signature of Osteochondritis Dissecans in a Cross-Sectional Study
por: Gabusi, Elena, et al.
Publicado: (2018) -
Focal Defects of the Knee Articular Surface: Evidence of a Regenerative Potential Pattern in Osteochondritis Dissecans and Degenerative Lesions
por: Gabusi, Elena, et al.
Publicado: (2017)